THOMAS A BUCHHOLZ to Lung Neoplasms
This is a "connection" page, showing publications THOMAS A BUCHHOLZ has written about Lung Neoplasms.
Connection Strength
0.332
-
Lung carcinoma development after radiotherapy for breast carcinoma. Cancer. 2003 Oct 01; 98(7):1331-3.
Score: 0.048
-
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer. 2015 Dec 15; 121(24):4324-32.
Score: 0.027
-
Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015 Jul; 6(4):324-31.
Score: 0.027
-
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol. 2015 May; 115(2):257-63.
Score: 0.027
-
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014 Dec; 149(12):1244-53.
Score: 0.026
-
Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis. Chest. 2014 May; 145(5):1097-1113.
Score: 0.025
-
Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest. 2014 Feb; 145(2):331-345.
Score: 0.024
-
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities. Lung Cancer. 2013 Nov; 82(2):252-9.
Score: 0.024
-
Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol. 2013 May; 20(5):1514-21.
Score: 0.023
-
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1060-70.
Score: 0.022
-
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec; 30(6):2113-20.
Score: 0.021
-
Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009 Jun 10; 27(17):2758-65.
Score: 0.018
-
Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report. Int J Oncol. 2000 Aug; 17(2):399-404.
Score: 0.010
-
Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15; 5(13):5076-86.
Score: 0.006
-
MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin Cancer Res. 2011 Sep 01; 17(17):5638-48.
Score: 0.005